If there is one content management challenge that is causing compliance headaches for international life sciences organisations, it is labelling. Over-reliance on manual processes to cross-check content interdependencies, and to manage requirements for each country whenever something changes, leaves companies at risk of delays to market or even registrations being withdrawn. Agnes Cwienczek of AMPLEXOR considers how they can turn this situation around.
[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2019/07/Connected-labelling_the-holy-grail.pdf” width=”100%” height=”900px” style=”border:0;”]
